Company intelligence / Profile preview
Fluart Innovative Vaccines
Pilisborosjenő, Pest, Hungary
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Fluart has completed multiple clinical trials for its seasonal trivalent/quadrivalent influenza vaccines in both adults and children, demonstrating immunogenicity and safety consistent with regulatory requirements for such products. Its lead products have reached late-stage development or post-marketing studies within Hungary.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineBiologicBacteriophage
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Fluart Innovative Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fluart Innovative Vaccines.